171 related articles for article (PubMed ID: 17611763)
1. Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients.
Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
Int J Colorectal Dis; 2007 Oct; 22(10):1195-200. PubMed ID: 17611763
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
[TBL] [Abstract][Full Text] [Related]
3. Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease.
Yadav AK; Kumar V; Jha V
Indian J Nephrol; 2016; 26(4):275-9. PubMed ID: 27512300
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between CX3CR1 V249I and T280M polymorphisms and risk of Parkinson's disease in a Greek population.
Kalinderi K; Bostantjopoulou S; Katsarou Z; Clarimón J; Fidani L
Genet Test Mol Biomarkers; 2012 Aug; 16(8):974-7. PubMed ID: 22747084
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
Niessner A; Marculescu R; Haschemi A; Endler G; Zorn G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
Thromb Haemost; 2005 May; 93(5):949-54. PubMed ID: 15886814
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophy of the ligament flavum in degenerative lumbar stenosis associated with the increased expression of fractalkine (CX3CL1)/CX3CR1 chemokine.
Oh IS; Suh DW; Ha KY
Connect Tissue Res; 2013; 54(6):380-5. PubMed ID: 24060055
[TBL] [Abstract][Full Text] [Related]
7. The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination.
Erreni M; Siddiqui I; Marelli G; Grizzi F; Bianchi P; Morone D; Marchesi F; Celesti G; Pesce S; Doni A; Rumio C; Roncalli MG; Laghi L; Mantovani A; Allavena P
J Immunol; 2016 Jan; 196(2):902-14. PubMed ID: 26673138
[TBL] [Abstract][Full Text] [Related]
8. Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis.
Bagci B; Bagci G; Huzmeli C; Sezgin I; Ozdemir O
Int Urol Nephrol; 2016 Jul; 48(7):1163-70. PubMed ID: 27118566
[TBL] [Abstract][Full Text] [Related]
9. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
[TBL] [Abstract][Full Text] [Related]
10. Fractalkine receptor polymorphism may not be associated with the development and clinical course of ulcerative colitis.
Gokcan H; Yurtcu E; Selcuk H; Sahin FI
Bosn J Basic Med Sci; 2015 May; 15(2):73-7. PubMed ID: 26042517
[TBL] [Abstract][Full Text] [Related]
11. Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity.
Sirois-Gagnon D; Chamberland A; Perron S; Brisson D; Gaudet D; Laprise C
Obesity (Silver Spring); 2011 Jan; 19(1):222-7. PubMed ID: 20523302
[TBL] [Abstract][Full Text] [Related]
12. Association of
Woźny Ł; Żywiec J; Gosek K; Kuźniewicz R; Górczyńska-Kosiorz S; Trautsolt W; Śnit M; Grzeszczak W
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33672355
[TBL] [Abstract][Full Text] [Related]
13. Fractalkine and its receptor (CX3CR1) in patients with stable coronary artery disease and diabetes mellitus.
Njerve IU; Pettersen AÅ; Opstad TB; Arnesen H; Seljeflot I
Metab Syndr Relat Disord; 2012 Dec; 10(6):400-6. PubMed ID: 22897138
[TBL] [Abstract][Full Text] [Related]
14. Influence of fractalkine receptor gene polymorphisms V249I-T280M on cancer occurrence after renal transplantation.
Courivaud C; Bamoulid J; Loupy A; Deschamps M; Ferrand C; Simula-Faivre D; Tiberghien P; Chalopin JM; Legendre C; Thervet E; Borg C; Saas P; Ducloux D
Transplantation; 2013 Mar; 95(5):728-32. PubMed ID: 23388733
[TBL] [Abstract][Full Text] [Related]
15. Association of circulating fractalkine (CX3CL1) and CX3CR1(+)CD4(+) T cells with common carotid artery intima-media thickness in patients with chronic kidney disease.
Yadav AK; Lal A; Jha V
J Atheroscler Thromb; 2011; 18(11):958-65. PubMed ID: 21873805
[TBL] [Abstract][Full Text] [Related]
16. Fractalkine gene receptor polymorphism in patients with multiple sclerosis.
Arli B; Irkec C; Menevse S; Yilmaz A; Alp E
Int J Neurosci; 2013 Jan; 123(1):31-7. PubMed ID: 22916723
[TBL] [Abstract][Full Text] [Related]
17. T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease.
Hattori H; Ito D; Tanahashi N; Murata M; Saito I; Watanabe K; Suzuki N
Neurosci Lett; 2005 Feb; 374(2):132-5. PubMed ID: 15644279
[TBL] [Abstract][Full Text] [Related]
18. The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.
Wasmuth HE; Zaldivar MM; Berres ML; Werth A; Scholten D; Hillebrandt S; Tacke F; Schmitz P; Dahl E; Wiederholt T; Hellerbrand C; Berg T; Weiskirchen R; Trautwein C; Lammert F
J Hepatol; 2008 Feb; 48(2):208-15. PubMed ID: 18078680
[TBL] [Abstract][Full Text] [Related]
19. Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.
Nassar BA; Nanji AA; Ransom TP; Rockwood K; Kirkland SA; Macpherson K; Connelly PW; Johnstone DE; O'Neill BJ; Bata IR; Andreou P; Title LM
Scand J Clin Lab Invest; 2008; 68(4):286-91. PubMed ID: 18609106
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of fractalkine receptor CX3CR1 gene in patients with symptomatic and asymptomatic carotid artery stenosis.
Kimouli M; Miyakis S; Georgakopoulos P; Neofytou E; Achimastos AD; Spandidos DA
J Atheroscler Thromb; 2009 Oct; 16(5):604-10. PubMed ID: 19755791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
